GABPβ1L Wakes Up TERT

Gilbert J Rahme1, Elizabeth Gaskell1, Bradley E Bernstein1

  • 1Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Cancer Cell
|September 12, 2018
PubMed

Insights

The telomerase (TERT) enzyme is crucial for cancer cell immortality. Researchers found that GABPβ1L protein is essential for the activity of mutated TERT promoters, offering a new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Telomere maintenance is critical for cellular replication.
  • The enzyme telomerase (TERT) is typically silenced in somatic cells but reactivated in many cancers.
  • TERT promoter mutations are a common mechanism driving cancer cell proliferation.

Purpose of the Study:

  • To investigate the regulatory mechanisms of mutant TERT promoter activity in cancer.
  • To identify potential therapeutic targets for cancers with aberrant TERT expression.

Main Methods:

  • Analysis of TERT promoter activity in cancer cells.
  • Investigating the role of transcription factors in regulating TERT expression.
  • Utilizing genetic and molecular biology techniques to assess protein function.

Main Results:

  • The transcription factor GABPβ1L was identified as essential for the activity of mutant TERT promoters.
  • GABPβ1L directly binds to and activates the mutated TERT promoter.
  • Inhibition of GABPβ1L significantly reduced TERT expression and cancer cell proliferation.

Conclusions:

  • GABPβ1L is a key regulator of oncogenic TERT expression.
  • Targeting GABPβ1L represents a promising therapeutic strategy for cancers dependent on TERT for immortality.